lundi 13 juillet 2020

Global HIV Partnering 2012 to 2018: Deals Listed by Company A-Z, Industry Sector, Stage of Development & Technology Type –

Par Rédaction , dans Communiqués , le 12 mars 2018

Monday, March 12th 2018 at 2:28pm UTC

HIV Partnering 2012 to 2018 »
report has been added to’s

The Global HIV Partnering Terms and Agreements since 2012 report
provides understanding and access to partnering deals and agreements
entered into by the world’s leading healthcare companies.

The report provides an analysis of partnering deals. The majority of
deals are discovery or development stage whereby the licensee obtains a
right or an option right to license the licensors technology. These
deals tend to be multicomponent, starting with collaborative R&D, and
commercialization of outcomes.

Understanding the flexibility of a prospective partner’s negotiated
deals terms provides critical insight into the negotiation process in
terms of what you can expect to achieve during the negotiation of terms.
Whilst many smaller companies will be seeking details of the payments
clauses, the devil is in the detail in terms of how payments are
triggered – contract documents provide this insight where press releases
do not.

This data driven report contains multiple links to online copies of
actual deals and contract documents as submitted to the Securities
Exchange Commission by companies and their partners, where available.
Contract documents provide the answers to numerous questions about a
prospective partner’s flexibility on a wide range of important issues,
many of which will have a significant impact on each party’s ability to
derive value from the deal.

In conclusion, this report provides everything a prospective dealmaker
needs to know about partnering in the research, development and
commercialization of technologies and products in the therapy area.

Key Topics Covered:

Executive Summary

Chapter 1 – Therapy Partnering trends in numbers

Chapter 2 – Most active dealmakers

Chapter 3 – Partnering deals directory

Chapter 4 – Partnering deals with a contract document

Chapter 5 – M&A in numbers

Chapter 6 – M&A deals directory

Chapter 7 – Financing in numbers

Chapter 8 – Financing deals directory

For more information about this report visit

Laura Wood, Senior Manager
E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
For GMT Office Hours Call +353-1-416-8900
Topics: HIV/AIDS

Source: Research and Markets

Étiquettes :